"Contract research organizations have the expertise, (...) necessary to develop and run a successful #clinicaltrial that complies with regulatory #standards. Working with a #CRO can (...) speed up the timeline and reduce the cost of a study."
https://t.co/FLdmpcThLP
ethica CRO successfully designed and managed pivotal study that led to the FDA’s first approval of a dermal filler for the treatment of acne scars.#dermatologytrials#dermatology#dermalfillers
https://t.co/kXT4ZjXkYS
“We are now working rapidly in preparing our IND submission for the 2B portion of the study which we believe will be next month. Once cleared, we will move swiftly into patient recruitment.”
"It’s important for dermatologists to ensure their technology infrastructure lines up with the logistics of an efficient visit, such as having quality image-capturing ability and making sure the telehealth platform integrates with an organization’s EHR system." #teledermatology
"Large decreases from baseline in GRID-HAMD scores were observed at 1-, 3-, 6-, and 12-month follow-up ... Treatment response (⩾50% reduction in GRID-HAMD score from baseline) and remission were 75% and 58%, respectively, at 12 months." #mentalhealth#depression
Long-term (12 month follow-up) results of our waiting-list controlled study of psilocybin-assisted therapy for MDD are out today in JOP: https://t.co/pm0WV55CMl 1/ 🧵
Lack of diversity of patients enrolled in #dermatology trials has not changed significantly, according to literature reviews between 2010 and 2020. https://t.co/TDJ80baNIa Via @JAMADerm
The long-awaited National Standard of Canada, CAN/HRSO-300.01-2022 “Conduct of Human Research” is available for public consultation until April 12th. 👉 https://t.co/oTmHEkD9pr
Looking forward to your comments! #StandardsMatter#InnovateWithStandards#research
At ethica CRO, the research participant lies at the heart of what we do. ethica CRO is the 1st accredited Contact Research Organization in the world and an industry leader in research ethics. #clinicaltrials#researchethics#clinicalresearch https://t.co/DFi5upmSuv
In this video, Dr Robert Kalb defines what are treatment targets for psoriasis and how often should dermatologists evaluate a patient’s progression toward a treatment target. Watch here: https://t.co/G6ZodhvO0Z
#dermtwitter#psoriasis#dermatology
Another successful completion of @Teoxane dermal filler study by the ethica CRO team! Congratulations and thank you to employees and partners for their collaboration! #dermalfillers#dermatology https://t.co/wF4uKQBba4
"Well-developed #clinicaltrials are required to determine the true clinical efficacy of BoNT in the off-label setting, as well as possible long-term safety concerns." #dermatology@EMJReviews https://t.co/SSfpN9UMWQ
"There is #innovation in the form of novel treatments in the pipeline. There is increased awareness. There is hope. But until such positive changes bear fruit, it’s time to reconsider a great deal about the severe and underserved types of depression." #mentalhealth#research
#happyholidays from everyone at ethica CRO! Thank you to our employees, our clients, investigators, vendors, and consultants for your support. A special thank you to all research participants who have given their time and energy to the advancement of science and medicine.
Looking forward to see you at our upcoming @cara_acaar presentation on the recently published National Standard of Canada "Ethical Review and Oversight of Human Research"!
Register here: https://t.co/mkey6zL0Wh
@JaniceParente @alkarabanow @LetendreMartin#StandardsMatter
On this #thanksgiving we want to share our gratitude to our employees, our clients, our investigators, and our vendors who are presently celebrating in the U.S. Thank you for your continued trust. On behalf of everyone at ethica CRO, #happythanksgiving !
“If we want to see #psychedelics as a part of our healthcare system, we need to have much broader research and we need to do it in the pursuit of a good and positive societal impact” #Psilocybin@MydecineIG@RollingStone https://t.co/IVFdqm88t4
“This is a historic moment. The long-awaited malaria vaccine for children is a breakthrough for science” said @WHO Director-General “Using this vaccine on top of existing tools to prevent malaria could save tens of thousands of young lives each year.” https://t.co/c737F9mEXB